Director of Structural Interventions
Piedmont Atlanta Hospital
Atlanta, Georgia, United States
Dr. Pradeep Yadav is an Interventional Cardiologist and the Director of Structural Interventions at Piedmont Heart Institute, Atlanta, GA. His primary focus is on investigating early device / technologies for the treatment of valvular heart disease.
Disclosure(s): Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)
Topaz TTVR – Initial Case Experience and EFS Update
Saturday, March 8, 2025
4:18 PM – 4:26 PM ET
Saturday, March 8, 2025
4:34 PM – 5:00 PM ET
Live Case Broadcasting from Piedmont | Atlanta, GA
Sunday, March 9, 2025
3:00 PM – 3:45 PM ET
How I Prepare To Treat TAV-in-TAV With A Dedicated Leaflet Modification Device
Sunday, March 9, 2025
8:12 AM – 8:20 AM ET
Early Results from TTVR with the Trisol Valve System
Monday, March 10, 2025
12:17 PM – 12:25 PM ET
Tuesday, March 11, 2025
8:40 AM – 8:48 AM ET
Panel Discussion | Second- and Third-Generation Aortic Valve Systems Not Yet Approved in the US
Tuesday, March 11, 2025
9:36 AM – 10:00 AM ET
Panel Discussion | Tricuspid | Do we have the Right Tools to Address the Unmet Clinical Need?
Tuesday, March 11, 2025
10:00 AM – 10:20 AM ET